Category: FDA

3 6/22/2016

What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug

6/13/2016

21st Century Cures Act nears passage with little news media scrutiny

3 5/23/2016

Inside the Sausage Factory of Drug Approval: Nuplazid (pimavanserin) coverage didn’t inspect closely enough

8 4/20/2016

Media mystery: Why did journalists ignore an important study on a costly, harmful back pain procedure?

4 3/16/2016

Coverage of Amarin off-label promotion agreement should have acknowledged deadly history of such marketing

1 2/29/2016

Precision Medicine at one year: A soaring White House summit and the potholes ahead

7 2/10/2016

Groups push pharma agenda under the guise of patient advocacy

1/15/2016

Faulty medical devices stay on the market even after manufacturers know there are problems

3 1/7/2016

“Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny

5 1/5/2016

FDA teams up with medical device industry to write 21st Century Cures Act